DFE Pharma Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
450
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
DFE Pharma General Information
Description
Developer, producer, and supplier of excipients intended for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company provides a wide range of excipient products and services for respiratory, oral solid dose (OSD), ophthalmic, and parenteral formulations, helping pharmaceutical companies offer medicine that delivers the appropriate treatment outcomes for patients.
Contact Information
Website
www.dfepharma.comCorporate Office
- Klever Strasse 187
- 47574 Goch
- Germany
Corporate Office
- Klever Strasse 187
- 47574 Goch
- Germany
DFE Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DFE Pharma Comparisons
Industry
Financing
Details
DFE Pharma Competitors (6)
One of DFE Pharma’s 6 competitors is Ropack Pharma Solutions, a Corporation company based in Montreal, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ropack Pharma Solutions | Corporation | Montreal, Canada | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Catalent | Private Equity-Backed | Tampa, FL | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Lilly USA | Corporation | Indianapolis, IN |
DFE Pharma Patents
DFE Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4791363-A1 | Method and system for preparing agglomerated excipient granules | Pending | 12-Oct-2023 | ||
| WO-2025078588-A1 | Method and system for preparing agglomerated excipient granules | Inactive | 12-Oct-2023 | ||
| EP-4380622-A1 | Method for preparing co-processed excipient granules | Active | 03-Aug-2021 | ||
| EP-4380622-B1 | Method for preparing co-processed excipient granules | Active | 03-Aug-2021 | ||
| EP-4380622-C0 | Method for preparing co-processed excipient granules | Active | 03-Aug-2021 | A61K9/1694 |
DFE Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DFE Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
DFE Pharma FAQs
-
When was DFE Pharma founded?
DFE Pharma was founded in 2006.
-
Where is DFE Pharma headquartered?
DFE Pharma is headquartered in Goch, Germany.
-
What is the size of DFE Pharma?
DFE Pharma has 450 total employees.
-
What industry is DFE Pharma in?
DFE Pharma’s primary industry is Discovery Tools (Healthcare).
-
Is DFE Pharma a private or public company?
DFE Pharma is a Private company.
-
What is the current valuation of DFE Pharma?
The current valuation of DFE Pharma is .
-
What is DFE Pharma’s current revenue?
The current revenue for DFE Pharma is .
-
Who are DFE Pharma’s investors?
CVC Capital Partners and Royal FrieslandCampina have invested in DFE Pharma.
-
Who are DFE Pharma’s competitors?
Ropack Pharma Solutions, Zydus Lifesciences, Catalent, Cipla, and Lilly USA are some of the 6 competitors of DFE Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
